These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30036981)

  • 1. Genome-Scale Metabolic Model of
    Li J; Sun R; Ning X; Wang X; Wang Z
    Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30036981
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolomic change and pathway profiling reveal enhanced ansamitocin P-3 production in Actinosynnema pretiosum with low organic nitrogen availability in culture medium.
    Liu T; Yang L; Chen J; Hu F; Wei LJ; Hua Q
    Appl Microbiol Biotechnol; 2020 Apr; 104(8):3555-3568. PubMed ID: 32114676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Genome Sequence of Actinosynnema pretiosum X47, An Industrial Strain that Produces the Antibiotic Ansamitocin AP-3.
    Zhong C; Zong G; Qian S; Liu M; Fu J; Zhang P; Li J; Cao G
    Curr Microbiol; 2019 Aug; 76(8):954-958. PubMed ID: 29858620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Engineering of Post-PKS Modification Bottlenecks for Ansamitocin P-3 Titer Improvement in Actinosynnema pretiosum subsp. pretiosum ATCC 31280.
    Ning X; Wang X; Wu Y; Kang Q; Bai L
    Biotechnol J; 2017 Nov; 12(11):. PubMed ID: 28881098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the Methylmalonyl-CoA Metabolic Pathway on Ansamitocin Production in Actinosynnema pretiosum.
    Zhao M; Fan Y; Wei L; Hu F; Hua Q
    Appl Biochem Biotechnol; 2017 Mar; 181(3):1167-1178. PubMed ID: 27787765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of traditional mutation and metabolic engineering to enhance ansamitocin P-3 production in Actinosynnema pretiosum.
    Du ZQ; Zhang Y; Qian ZG; Xiao H; Zhong JJ
    Biotechnol Bioeng; 2017 Dec; 114(12):2794-2806. PubMed ID: 28782796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased yield of AP-3 by inactivation of asm25 in Actinosynnema pretiosum ssp. auranticum ATCC 31565.
    Cheng H; Xiong G; Li Y; Zhu J; Xiong X; Wang Q; Zhang L; Dong H; Zhu C; Liu G; Chen H
    PLoS One; 2022; 17(3):e0265517. PubMed ID: 35316825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational approach to improve ansamitocin P-3 production by integrating pathway engineering and substrate feeding in Actinosynnema pretiosum.
    Du ZQ; Zhong JJ
    Biotechnol Bioeng; 2018 Oct; 115(10):2456-2466. PubMed ID: 29940067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics analysis of Actinosynnema pretiosum with improved AP-3 production by enhancing UDP-glucose biosynthesis.
    Liu T; Jin Z; Wang Z; Chen J; Wei LJ; Hua Q
    J Biosci Bioeng; 2020 Jul; 130(1):36-47. PubMed ID: 32179024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of modulation of pentose-phosphate pathway on biosynthesis of ansamitocins in Actinosynnema pretiosum.
    Fan Y; Hu F; Wei L; Bai L; Hua Q
    J Biotechnol; 2016 Jul; 230():3-10. PubMed ID: 27173582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved AP-3 production through combined ARTP mutagenesis, fermentation optimization, and subsequent genome shuffling.
    Li J; Guo S; Hua Q; Hu F
    Biotechnol Lett; 2021 Jun; 43(6):1143-1154. PubMed ID: 33751317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process optimization with alternative carbon sources and modulation of secondary metabolism for enhanced ansamitocin P-3 production in Actinosynnema pretiosum.
    Fan Y; Gao Y; Zhou J; Wei L; Chen J; Hua Q
    J Biotechnol; 2014 Dec; 192 Pt A():1-10. PubMed ID: 25456055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Guided Discovery of Pretilactam from
    Wang J; Hu X; Sun G; Li L; Jiang B; Li S; Bai L; Liu H; Yu L; Wu L
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31248172
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancement of UDPG synthetic pathway improves ansamitocin production in Actinosynnem pretiosum.
    Fan Y; Zhao M; Wei L; Hu F; Imanaka T; Bai L; Hua Q
    Appl Microbiol Biotechnol; 2016 Mar; 100(6):2651-62. PubMed ID: 26585444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two strategies to improve the supply of PKS extender units for ansamitocin P-3 biosynthesis by CRISPR-Cas9.
    Guo S; Sun X; Li R; Zhang T; Hu F; Liu F; Hua Q
    Bioresour Bioprocess; 2022 Aug; 9(1):90. PubMed ID: 38647752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Regulator AdpA_1075 Regulates Morphological Differentiation and Ansamitocin Production in
    Guo S; Leng T; Sun X; Zheng J; Li R; Chen J; Hu F; Liu F; Hua Q
    Bioengineering (Basel); 2022 Nov; 9(11):. PubMed ID: 36421120
    [No Abstract]   [Full Text] [Related]  

  • 17. Biosynthesis of ansamitocin P-3 incurs stress on the producing strain Actinosynnema pretiosum at multiple targets.
    Huang Q; Zhang X; Guo Z; Fu X; Zhao Y; Kang Q; Bai L
    Commun Biol; 2023 Aug; 6(1):860. PubMed ID: 37596387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Antitumor Agent Ansamitocin P-3 Binds to Cell Division Protein FtsZ in
    Wang X; Wang R; Kang Q; Bai L
    Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux identification and engineering for ansamitocin P-3 production in Actinosynnema pretiosum.
    Wang X; Wei J; Xiao Y; Luan S; Ning X; Bai L
    Appl Microbiol Biotechnol; 2021 Jan; 105(2):695-706. PubMed ID: 33394151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic studies on anti-tumor agent ansamitocin P-3 producer Actinosynnema pretiosum in response to ammonium and isobutanol.
    Lin J; Zhong JJ
    Bioprocess Biosyst Eng; 2017 Jul; 40(7):1133-1139. PubMed ID: 28382459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.